HHS Delays Trump-Era Drug Rebate Rule to 2023 After Court Order

The HHS on Thursday delayed until 2023 a Trump administration rule that would have altered payments from drugmakers to pharmacy middlemen.

The postponement follows a court order that also holds litigation about the rule in abeyance pending a review by the Department of Health and Human Services.

A pharmacy liaison group argued the changes would significantly disrupt negotiations with drugmakers.

The rule (0936-AA08), which changes payments to pharmacy benefit managers such that they can’t fluctuate based on the price of a drug, was slated to take effect January 2022. Judge John D. Bates of the U.S. District Court for the ...